Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lee Fairlie

Associate Professor/Reader

University of Witwatersrand

South Africa

Research Interests

Explore related searches

Professors in Immunology

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (9)

María García-Cremades

Assistant Professor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Jonathon Campbell

Assistant Professor

McGill University

CANADA

View details

James A. Seddon

Professor Extraordinary

Stellenbosch University

SOUTH AFRICA

View details

Ahizechukwu C. Eke, MD PhD

Associate Professor of Maternal Fetal Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

Trinh Duong

University College London

UNITED KINGDOM

View details

Funeka Bango

Senior Scientist

South African Medical Research Council

SOUTH AFRICA

View details

Rebecca Turner

University College London

UNITED KINGDOM

View details

Robert Wilkinson

Group Leader

The Francis Crick Institute

UNITED KINGDOM

View details

Jay Achar

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lee Fairlie

Research Interests

Explore related searches

Articles (20)

Rethinking HIV antibody testing in children aged 18-24 months in the OPPTIM study conducted in Johannesburg, South Africa 2018-2021

Health system and household costs of preventive treatment delivery for children exposed to multidrug-resistant tuberculosis in South Africa

Letter Reply to “Mind the Postpartum Trough: Closing the Clofazimine Exposure Gap After Delivery in Rifampicin-Resistant Tuberculosis”

Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trial

Vaginal Microbiota and Cytokines Among Pregnant and Breastfeeding Women in Clinical Trials of the Dapivirine Vaginal Ring and Oral Tenofovir Disoproxil Fumarate/Emtricitabine

Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis

Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant Tuberculosis

Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial

Risk of Tuberculosis Infection in Young Children Exposed to Multidrug-resistant Tuberculosis in the TB-CHAMP Multi-site Randomized Controlled Trial

Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment

Characterizing the HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of “Universal Test and Treat”: A systematic review and meta‐analysis

Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective

BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection

Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial

Burden of Lassa fever disease in pregnant women and children and options for prevention

Clot twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS

Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial

Collaborators (9)

María García-Cremades

Jonathon Campbell

James A. Seddon

Ahizechukwu C. Eke, MD PhD

Trinh Duong

Funeka Bango

Rebecca Turner

Robert Wilkinson

Jay Achar

Make your next move.